Special Issue "Recent Advances in Therapeutic Strategies for the Treatment of Pediatric Diseases"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".

Deadline for manuscript submissions: 30 June 2023 | Viewed by 217

Special Issue Editors

Clinical Pathology, Pausilipon Hospital, A.O.R.N Santobono-Pausilipon, 80123 Naples, Italy
Interests: non coding RNA in cancer development; post-transcriptional regulation; effects of plant nanovesicles on cancer in vitro models; study of new therapeutic strategies for pediatric cancer diseases
UOS Laboratori di Ricerca e Biobanca, A.O.R.N Santobono-Pausilipon, 80123 Naples, Italy
Interests: cancer; leukemia; flow cytometry; microRNA; lncRNA; Alzheimer's disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

we are pleased to invite you to contribute to the Special Issue entitled “Recent Advances in Therapeutic Strategies for the Treatment of Pediatric Diseases”.

Gene therapy, biological drugs and innovative treatments are opening up new opportunities for diagnosis and treatment of children affected by different diseases such as immunodeficiencies, tumors, hematological disorders, genetic diseases and so on. Although to date a number of pediatric diseases are efficiently treated, any efforts in the development of new therapeutical strategies is appreciated in order to reduce side effects and ameliorate the life style of affected children.

This Special Issue aims to publish contributions on the different aspects related to the treatment of pediatric diseases. All types of articles are welcome, we encourage the submission of original research reports, reviews, minireviews, and perspectives focusing on the following specific topics regarding the treatment of pediatric diseases:

  • Effects of new drugs/compounds on in vitro and in vivo systems.
  • Identification of causative mutations and elucidation of molecular basis in pediatric diseases in order to design specific/personalized drugs.
  • Identification of biomarkers to follow up novel therapies.
  • Physiological and biochemical effects of drugs on the body.
  • Gene therapy.
  • Delivery systems for drugs, vaccines and biopharmaceuticals.

We look forward to receiving your contributions.

Dr. Mariaevelina Alfieri
Dr. Peppino Mirabelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • pediatric diseases 
  • drug discovery 
  • gene therapy 
  • drug delivery 
  • novel therapies 
  • new biomarkers 
  • molecular basis 
  • gene mutations 
  • therapeutic targets

Published Papers

This special issue is now open for submission.
Back to TopTop